James Wilbur - Nov 20, 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Commercial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for James Wilbur
Stock symbol
TXG
Transactions as of
Nov 20, 2023
Transactions value $
-$619,494
Form type
4
Date filed
11/22/2023, 04:30 PM
Previous filing
Aug 24, 2023
Next filing
Nov 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$619K -14.7K -14.5% $42.09 86.8K Nov 20, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $42.05 to $42.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2 Includes 271 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2023.